We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lonza Settles Patent Suits Vs. Axel and Stauber

Law360 (January 9, 2004, 12:00 AM EST) -- Swiss life-sciences company Lonza settled its patent infringement actions against Axel Chemicals LLC in and Stauber Performance Ingredients over a patent covering the production of solid oral dosage forms of the neutraceuticals L-carnitine L-tartrate for enteral administration.

L-carnitine is a nutrient beneficial for weight loss, athletic performance, and general cardiovascular health, according to Lonza.

Lonza had sued Axel Chemicals LLC in the U.S. District Court for the District of New Jersey in October 2002 and Stauber Performance Ingredients in the U.S. District Court for the Central...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.